Good day, everyone, and welcome to the 2026 Protagonist Therapeutics annual meeting. I'll turn the call over to your host, Matthew Gosling. Please go ahead, Matthew. Good morning. I am Matthew Gosling, EVP, Chief Legal and Business Officer of Protagonist Therapeutics Inc. I'm very happy to welcome you to the Protagonist Therapeutics 2026 stockholders meeting. I'm joined by Dr. Dinesh Patel, who's the President and CEO of the company, the chairman of this annual meeting, and a member of the board of directors of the company. Dr. Patel has asked me to serve as the secretary of this meeting and to review the items of business before stockholders today. As you know, we are hosting today's meeting through a virtual online platform hosted by Broadridge. Stockholders who are attending this meeting with a valid 16-digit control number will have the opportunity to submit questions or comments during the Q&A portion of this meeting through the text box located on your screen. We will try to answer any such questions submitted that are germane to the proposals or this meeting as and if we have time. Please submit your questions now to make sure they are received in a timely fashion for our review and response. We will screen incoming questions and will read the question out loud. Dr. Patel or another executive or board member will respond. If you intend to vote and have not already done so, you must submit your vote online now in order for it to be counted. After I describe each item to be voted on, we will close the polls. We will not accept ballots, proxies, revocations, or changes after the closing of the polls. If you have already submitted your vote by proxy and do not wish to change your vote, you do not need to vote now, your shares will be voted as previously instructed. Before I call the meeting to order, I'd like to introduce to you the members of the board and the executive officers who are with us today. The members of the board in addition to Dr. Patel are Harold Selick, Bryan Giraudo, Sarah O'Dowd, William Waddill, and Lewis Williams. In addition to Dr. Patel, the other executive officers of the company here today are Asif Ali and Arturo Molina. I'd also like to introduce Yogi Ramsing of Ernst & Young, the company's independent registered public accounting firm, and Maria Beltran of Broadridge Financial Solutions, who are also in attendance virtually and available to respond to appropriate questions as needed. The meeting will now officially come to order. This meeting is being recorded. We will proceed with the formal business of the meeting as set forth in your notice of annual meeting and proxy statement. We will first present the four proposals submitted for approval by our board. We will respond to questions related to the proposals after all of the proposals have been presented, after which polls will be closed, and we will announce the preliminary results of the voting. If you have not voted, I encourage you to vote online during this meeting. I have at this meeting a complete list of the stockholders of record of the company's common stock on April 22nd, 2026, which is the record date for this meeting. I also have an affidavit certifying that on April 28th, 2026, a notice of annual meeting of stockholders was deposited in the United States Mail to all stockholders of record at the close of business on the record date. I have been appointed as Inspector of Election at this meeting and have taken and subscribed the customary oath of office to execute these duties with strict impartiality. We will file this oath with the records of the meeting. This function is to decide upon the qualifications of voters, accept their votes, and when balloting on all matters is completed, to tally the final votes. Proxies have been received for 59,409,247 of the 64,305,185 shares of common stock outstanding on the record date, which represents approximately 92.4% of the total number of outstanding shares. This constitutes a quorum for the meeting today, and we may now carry out the official business of the meeting. We'll now proceed with the formal business of this meeting. After all of the proposals have been described, we will answer any questions related to the proposals submitted online. As a reminder, we ask that any questions or comments during this portion of the meeting pertain only to these proposals. Please submit any questions as soon as possible for our review. There are four proposals to be considered by the stockholders at this meeting. The time is now 10:05 A.M. on Wednesday, June 17th, 2026, and the polls are now open for voting on all matters to be presented. The polls will be closed to voting after I go through each of the proposals to be voted on. The first item of business is the election of two Class I director nominees to serve until the 2029 annual meeting and until his or her successors are elected. The nominees for Class I director are Dr. Dinesh Patel and Dr. Lewis Williams. The second item of business is to approve on a non-binding advisory basis the compensation of the company's named executive officers. The third item of business today is the ratification of Ernst & Young as the independent auditor for the company for 2026. The fourth item of business is to approve the adoption of the company's 2026 equity incentive plan. That was the final proposal for today's meeting. We'll now review if there are any questions about the aforementioned proposals before we close the polls. There are no further questions. The time is now 10:06 A.M., and the polls are now closed for voting. The report of the Inspector of Election covering the proposals presented at this meeting is as follows. The proposal to elect Dr. Patel and Dr. Williams as Class I directors of the company is carried. The advisory vote on the compensation of the company's named executive officers is approved. The selection of Ernst & Young as the company's independent auditor for 2026 is ratified, and the adoption of the company's 2026 equity incentive plan is approved. We expect to report the preliminary voting results, or if available to us on a timely basis, the final voting results on a current report on Form 8-K to be filed with the SEC within four business days after the end of this meeting. When earlier reported, we expect to report our final voting results in an amendment to our Form 8-K that's initially filed. The formal portion of today's meeting has ended, this meeting is concluded. Thank you. That concludes our meeting today. You may now disconnect.